Australian Primary Hemp has acquired 2 companies. It has also divested 1 asset.
Australian Primary Hemp has acquired in 2 countries. The Company’s most targeted sectors include healthcare services (50%) and metals/mining (50%).
53 Riversdale Road Newtown,
Geelong,
VIC 3220
Australia,
61 3 5201 0398
www.ausprimaryhemp.com.au
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2015-07-01 |
Alchemia Oncology Pty Ltd. · Life Science
Clayton, Australia Alchemia Oncology Pty Limited has a robust collection of clinical and pre-clinical oncology assets, which include the HyACT Drug Delivery Platform, a portfolio of targeted therapeutics which are designed to exploit the unique structure and inherent biological properties of Hyaluronic Acid. Drug candidates in the portfolio range from pre-clinical through phase 3. Panther intends to file a new phase 3 protocol against an open IND with the FDA for HA-Irinotecan in 2015, in addition to advancing the other phase 2 and phase 1b clinical drug candidates. |
- | Divestiture |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
